Phase III trials are conducted in which context?

• A. Initial small group to test safety
• B. Post-marketing surveillance after drug approval
• C. Large group, patients are monitored for effectiveness and side effects
• D. A process products have to go through to reach the market

Answer: (C)

Phase III trials focus on confirming effectiveness and safety in a large, diverse patient population. After initial safety checks in a small group (Phase I) and preliminary efficacy and dosing in a larger group (Phase II), Phase III uses many participants to determine real-world benefit, monitor a broad range of side effects, and compare the new treatment to current standard therapies. This large-scale testing provides the robust evidence needed for regulatory approval and labeling. Post-marketing surveillance (Phase IV) happens after approval to monitor long-term safety in the general population, which is why the description of a large group monitored for both effectiveness and side effects best fits Phase III.